GlaxoSmithKline Pharmaceuticals

BSE : 500660 | NSE : GLAXO

Industry : Pharma MNC | ISIN : INE159A01016 | FreeFloat : 50.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)1,358.45
Net Worth (NW)1,820.61
Intrinsic Worth (IW)3,179.06
Market Cap (MC)21,301.12
Economic Value Added86.47
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)42.73%
IC Gross Margin (EBITDA/IC)48.35%
IC Net Margin (NPT/IC)16.16%
Knowledge Turnover (Sales/IC)2.33
Market to Intrinsic Value (MC/IW)6.70

As OfIntrinsic ValueMarket Price
31 Mar 2020Rs. 187.66Rs. 1,257.40
26 May 2020 - Rs. 1,372.45
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesSell10 DMA : Rs. 1,383.56SellStrong Sell
KB > 50% : No50 DMA : Rs. 1,345.17
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-17
S
607.09
620.75
45.98
38.46
38.46
26.42
26.42
Sep-17
S
836.26
845.87
206.86
199.13
199.13
130.32
130.32
Dec-17
S
703.91
715.86
153.76
140.38
140.38
89.69
93.35
Mar-18
S
748.62
766.92
173.16
163.80
163.61
105.55
107.48
Jun-18
C
735.65
753.66
135.63
124.27
133.80
84.08
84.08
Sep-18
C
816.31
831.32
165.03
153.52
156.52
100.83
100.83
Dec-18
C
825.03
841.61
137.08
125.04
193.52
136.72
136.72
Mar-19
C
751.13
803.85
163.05
149.37
198.82
123.76
123.76
Jun-19
C
787.97
818.78
165.29
146.23
176.11
113.54
113.54
Sep-19
C
882.02
897.90
194.01
171.31
587.41
502.75
502.75
Dec-19
C
778.59
795.09
124.39
106.06
-634.32
-661.16
-661.16
Mar-20
C
775.80
791.62
200.65
178.06
176.55
138.07
138.60
* C - Consolidated, S - Standalone